Related Experiment Video
Updated: Jan 20, 2026

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
Dnmt3a is required for the tumor stemness of B16 melanoma cells
Haoyue Wang1,2, Ying Kuang3, Jun Li3
1School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Abstract:
The relationship of carcinogenesis and DNA methyltransferases has attracted extensive attention in tumor research. We reported previously that inhibition of de novo DNA methyltransferase 3a (Dnmt3a) in murine B16 melanoma cells significantly suppressed tumor growth and metastasis in xenografted mouse model. Here, we further demonstrated that knockdown of Dnmt3a enhanced the proliferation in anchor-independent conditions of B16 cells, but severely disrupted its multipotent differentiation capacity in vitro. Furthermore, transforming growth factor β1, a key trigger in stem cell differentiation and tumor cell epithelial-mesenchymal transition (EMT), mainly induced apoptosis, but not EMT in Dnmt3a-deficient B16 cells. These data suggested that Dnmt3a is required for maintaining the tumor stemness of B16 cells and it assists B16 cells to escape from death during cell differentiation. Thus it is hypothesized that not only extraordinary self-renewal ability, but also the capacity of multipotent differentiation is necessary for the melanoma tumorigenesis. Inhibition of multipotent differentiation of tumor cells may shed light on the tumor treatment.
Insights
DNA methyltransferase 3a (Dnmt3a) is crucial for maintaining melanoma tumor stemness and multipotent differentiation. Inhibiting Dnmt3a disrupts tumor cell survival and differentiation, offering potential new cancer treatment strategies.
Area of Science:
- Cancer Biology
- Epigenetics
- Melanoma Research
Background:
- The role of DNA methyltransferases in carcinogenesis is a significant area of cancer research.
- Previous studies indicated that inhibiting de novo DNA methyltransferase 3a (Dnmt3a) suppressed tumor growth and metastasis in a melanoma model.
Purpose of the Study:
- To investigate the role of Dnmt3a in maintaining the stemness and differentiation capacity of B16 melanoma cells.
- To explore the effect of Dnmt3a deficiency on tumor cell response to transforming growth factor β1 (TGF-β1).
Main Methods:
- Knockdown of Dnmt3a in murine B16 melanoma cells.
- Assessing proliferation under anchor-independent conditions.
- Evaluating multipotent differentiation capacity in vitro.
- Analyzing the induction of apoptosis and epithelial-mesenchymal transition (EMT) by TGF-β1.
Main Results:
- Dnmt3a knockdown enhanced anchorage-independent proliferation but severely impaired multipotent differentiation.
- Dnmt3a-deficient B16 cells primarily underwent apoptosis, not EMT, in response to TGF-β1.
- Dnmt3a appears essential for B16 cell stemness and survival during differentiation.
Conclusions:
- Dnmt3a is required for maintaining melanoma tumor stemness and multipotent differentiation capacity.
- Melanoma tumorigenesis may depend on both self-renewal and multipotent differentiation abilities.
- Targeting multipotent differentiation of tumor cells presents a potential therapeutic strategy for melanoma.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...
Adult Stem Cells
Embryonic Stem Cells
Proteins: Dietary Sources and Requirements
Oxygen Requirements and Growth Patterns

